<DOC>
	<DOCNO>NCT02929849</DOCNO>
	<brief_summary>The purpose study determine whether herb know alpha-glucosidase inhibitor property ( Salacia Chinensis , SC ) , affect postprandial appetite rating glucose index overweight/obese individual .</brief_summary>
	<brief_title>Satiety Glucose Indices Adults</brief_title>
	<detailed_description>Subjects randomly assign ( double blind ) 300 mg SC , 500 mg SC placebo use cross-over design three different day ( 1 month wash ) . Subjects consume capsule contain placebo treatment ( ) examine fix breakfast meal ( 50 % carbohydrate ; 30 % fat ; 20 % protein ) . Subjective appetite sensation rat use visual analog scale ( VAS ) hunger , satiety , fullness , prospective food intake . In addition , desire specific taste analyze measurement take twice breakfast ( fast baseline ) . After baseline screen blood draw , postprandial appetite taste perception rating blood obtain multiple time point 3 hour postprandial period ( 30 , 60 , 90 , 120,180 min ) . Blood analyze glucose/insulin , gut peptide , marker response meal .</detailed_description>
	<criteria>BMI 2535 Must willing able visit geographic vicinity New Brunswick , NJ ( BP ) [ systolic BP &gt; 140 and/or diastolic BP &gt; 90 ] Fasting blood glucose &gt; 126 Subject significant history current presence treat untreated bleeding disorder , diabetes mellitus , thyroid disease , tachyarrhythmia , heart disease , kidney disease , liver disease . History chronic condition prescription medication , surgery treatment Any significant GI condition would severely interfere evaluation study product include limited inflammatory bowel disease ( Ulcerative Colitis Crohn 's ) , history frequent diarrhea , history surgery weight loss ( include gastric bypass lapband ) , history perforation stomach intestine , gastroparesis , clinically important lactose intolerance History presence cancer prior two year . Participation clinical study exposure register nonregistered drug product within 30 day prior . Pregnant lactating woman . Subjects currently weight loss diet , weight loss regimen Subjects currently take prescription medication hypertension , cardiovascular disease , diabetes and/or chronic condition . Subject currently suffer sleep disorder and/or know history ( currently treat ) clinical depression , eat disorder ( ) psychiatric condition ( ) , opinion investigator , might put subject risk and/or confound result study . Subject know allergy sensitivity ingredient test product . Subject medical condition use medication , nutritional product , dietary supplement program , opinion investigator , might interfere conduct study place subject risk . Subject history difficulty swallow large pill tablet . Investigator uncertain subject 's capability willingness comply protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>